Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
CD103+ Conventional Dendritic Cells Are Critical for Corneal Allograft Survival
Author Affiliations & Notes
  • Tomas Blanco
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Hayate Nakagawa
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Rohan Bir Singh
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Yukako Taketani
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Hong yan Ge
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Nai-Wen Fan
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Yihe Chen
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Jia Yin
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Sunil Chauhan
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Reza Dana
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Tomas Blanco, None; Hayate Nakagawa, None; Rohan Singh, None; Yukako Taketani, None; Hong yan Ge, None; Nai-Wen Fan, None; Yihe Chen, None; Jia Yin, None; Sunil Chauhan, None; Reza Dana, None
  • Footnotes
    Support  R01 EY012963, R21 EY029387, P30 EY003790
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4362. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tomas Blanco, Hayate Nakagawa, Rohan Bir Singh, Yukako Taketani, Hong yan Ge, Nai-Wen Fan, Yihe Chen, Jia Yin, Sunil Chauhan, Reza Dana; CD103+ Conventional Dendritic Cells Are Critical for Corneal Allograft Survival. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4362.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Conventional type 1 CD103+ dendritic cells (cDC1) induce immune tolerance by promoting conversion of naïve CD4+T cells to Foxp3+ regulatory T cells (Tregs). Herein, we examined the role of CD103+ DCs in corneal allograft survival.

Methods : Allogeneic corneal transplantation was performed using C57BL/6J mice as donors and BALB/c as recipients. CD103+ DCs were depleted in recipients with subconjunctival injection of anti-CD103-saporin conjugated antibody (SAP). On day 3, naïve Tregs, antigen specific Tregs or CD4+CD25- T cells were subconjunctivally injected (1x105, syngeneic ) to graft recipients and PBS injections were used as controls. Bone marrow derived induced-CD103+DCs (iCD103+, 1x104) where subconjunctivally injected to evaluate their tolerogenic efficacy, and iCD11b DCs injected mice were used as negative controls. Animals were followed up for 8 weeks. Corneas and dLNs were assessed by flow cytometry. Additionally, CD103+ DCs were FACS sorted and evaluated by PCR

Results : CD103+ DCs were successfully depleted in cornea(<1%,p<0.001), conjunctiva(<1%, p<0.001) and dLN(<1%,p<0.001) of SAP treated mice compared to controls by day 7. Allografts were rejected in SAP treated mice (100%, p<0.001) compared to controls (55%). Injection of Tregs moderately extended graft survival compared to SAP, but <20% (naïve,p<0.001) or <35% (antigen-specific,p<0.001) grafts survived after 8 weeks compared to controls. All the grafts were rejected in CD4+CD25- T cell injected mice (p<0.001). Adoptive transfer of iCD103 DCs significantly increased graft survival to 90% (p<0.001), whereas 100% of grafts were rejected in mice inkected witht iCD11b-(100%, p<0.001). Mice treated with iCD103 DCs showed significantly increased Treg frequency (14.3%, p<0.01) and FoxP3 expression [1.5-fold (p<0.01)] compared to either iCD11b (10.3%) or PBS (11%) treated controls. IFNγ expression was significantly decreased in dLNs (0.40%, p<0.01) of iCD103 recipient mice compared to iCD11b (2.48%) or PBS (0.90%) controls. Additionally, mRNA expression of Irf8, Itgb8, Itgae, Clec9a, Cd274 and Xcr1 genes in cornea, conjunctiva and dLN was significantly upregulated in transplanted mice (p<0.001) compared to normal.

Conclusions : These results signify the critical role of CD103+ DCs in promoting tolerance and allograft survival. These findings suggest a possible therapeutic potential of adoptively transferred CD103+ cells in preventing allograft rejection.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×